Although these imaging and fluid biomarkers have provided significant insights into AD pathology relative to Aβ and tau pathology, additional biomarkers are needed to understand how Aβ and tau alter neuronal integrity, structure, and function for early diagnosis and staging of AD.15 Here, MAPT is linked to Alzheimer disease.